Related Experiment Video
Updated: Jul 6, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Michael H Tatham1, Marie-Claude Geoffroy, Linnan Shen
1Wellcome Trust Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
Abstract:
In acute promyelocytic leukaemia (APL), the promyelocytic leukaemia (PML) protein is fused to the retinoic acid receptor alpha (RAR). This disease can be treated effectively with arsenic, which induces PML modification by small ubiquitin-like modifiers (SUMO) and proteasomal degradation. Here we demonstrate that the RING-domain-containing ubiquitin E3 ligase, RNF4 (also known as SNURF), targets poly-SUMO-modified proteins for degradation mediated by ubiquitin. RNF4 depletion or proteasome inhibition led to accumulation of mixed, polyubiquitinated, poly-SUMO chains. PML protein accumulated in RNF4-depleted cells and was ubiquitinated by RNF4 in a SUMO-dependent fashion in vitro. In the absence of RNF4, arsenic failed to induce degradation of PML and SUMO-modified PML accumulated in the nucleus. These results demonstrate that poly-SUMO chains can act as discrete signals from mono-SUMOylation, in this case targeting a poly-SUMOylated substrate for ubiquitin-mediated proteolysis.
Insights
RNF4 targets poly-SUMOylated proteins for degradation. In acute promyelocytic leukaemia, RNF4 is crucial for arsenic-induced PML degradation, highlighting SUMO chains as degradation signals.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Acute promyelocytic leukaemia (APL) involves PML-RAR fusion protein.
- Arsenic therapy for APL induces PML modification and degradation.
- The role of ubiquitin E3 ligases in SUMO-mediated protein degradation is emerging.
Purpose of the Study:
- To investigate the role of RNF4 in targeting poly-SUMOylated proteins for degradation.
- To determine if RNF4 mediates the arsenic-induced degradation of PML in APL.
Main Methods:
- RNF4 depletion and proteasome inhibition experiments.
- In vitro ubiquitination assays.
- Immunofluorescence and Western blot analysis of PML and SUMOylated proteins.
Main Results:
- RNF4 depletion or proteasome inhibition caused accumulation of polyubiquitinated and poly-SUMOylated proteins.
- PML protein accumulated in RNF4-depleted cells and was ubiquitinated by RNF4 in a SUMO-dependent manner.
- Arsenic failed to induce PML degradation in the absence of RNF4, leading to nuclear accumulation of SUMO-modified PML.
Conclusions:
- Poly-SUMO chains act as distinct signals for protein degradation.
- RNF4 is a key E3 ligase that targets poly-SUMOylated proteins, including PML, for ubiquitin-mediated proteolysis.
- RNF4 is essential for the therapeutic efficacy of arsenic in APL by mediating PML degradation.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulation of Nuclear Protein Sorting
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Nuclear Export of mRNA
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Transcriptional Regulation: Riboswitches
